Stratec SE (ETR:SBS)

Germany flag Germany · Delayed Price · Currency is EUR
17.70
-0.08 (-0.45%)
May 8, 2026, 5:35 PM CET
Market Cap215.16M -29.8%
Revenue (ttm)250.86M -2.6%
Net Income-242.00K
EPS-0.02
Shares Out12.16M
PE Ration/a
Forward PE12.70
Dividend0.60 (3.39%)
Ex-Dividend DateJun 24, 2026
Volume15,897
Average Volume11,826
Open17.82
Previous Close17.78
Day's Range17.62 - 17.90
52-Week Range16.34 - 33.10
Beta0.79
RSI46.13
Earnings DateApr 28, 2026

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is h... [Read more]

Sector Healthcare
Founded 1979
Employees 1,343
Stock Exchange Deutsche Börse Xetra
Ticker Symbol SBS
Full Company Profile

Financial Performance

Financial Statements